Skip to main navigation
Logo

Investors

SEC Filing Details

Document Details

Form
8-K
Filing Date
Jun 24, 2024
Document Date
Jun 19, 2024
Form Description
Report of unscheduled material events or corporate event
Filing Group
Current Reports
Company
AN2 Therapeutics, Inc
Issuer
AN2 THERAPEUTICS, INC.

Filing Formats

iXBRL
View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE
EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
XML - XBRL INSTANCE DOCUMENT

Shareholder Tools

Print Page
Email Alerts
RSS Feeds
Investor Contact
  • Investor Overview
  • News & Events
    • Press Releases
    • Events
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • Corporate Governance
    • Documents & Charters
    • Committee Composition
  • Financial Information
    • SEC Filings
  • IR Resources
    • Email Alerts
    • Contact IR
  • More
    • About Us
      • Mission
      • Leadership
      • Board of Directors
      • Founders
      • Partners
      • Key Advisors
      • Expanded Access Policy
    • Technology
    • Pipeline
      • AN2-502998 (oral)
      • Chagas
      • Epetraborole
      • NTM
      • Melioidosis
      • Clinical Trials
      • Presentations and Publications
    • Investors
      • Investor Overview
      • News & Events
        • Press Releases
        • Events
      • Stock Information
        • Stock Quote & Chart
        • Analyst Coverage
      • Corporate Governance
        • Documents & Charters
        • Committee Composition
      • Financial Information
        • SEC Filings
      • IR Resources
        • Email Alerts
        • Contact IR
    • Careers
      • Job Opportunities
      • Values
      • Benefits
    • Contact
    • Home
    • About Us
      • Mission
      • Leadership
      • Board of Directors
      • Founders
      • Partners
      • Expanded Access Policy
    • Technology
    • Pipeline
      • Epetraborole
      • NTM
    • Investors
      • Investor Overview
      • News & Events
        • Press Releases
        • Events
      • Stock Information
        • Stock Quote & Chart
        • Analyst Coverage
      • Corporate Governance
        • Documents & Charters
        • Committee Composition
      • Financial Information
        • SEC Filings
      • IR Resources
        • Email Alerts
        • Contact IR
    • Careers
      • Job Opportunities
      • Values
      • Benefits
    • Contact
    • Privacy Policy
    • Terms of Use
    Logo

    Location
    1800 El Camino Real, Suite D
    Menlo Park, CA 94027
    Phone: 650-331-9090

    General Information
    info@an2therapeutics.com

    Investor & Media Inquiries
    info@an2therapeutics.com

    Job Inquiries
    careers@an2therapeutics.com

    Business Development Contact
    partner@an2therapeutics.com

    linkedin

    • Privacy Policy
    • Terms of Use
    © 2024 AN2 Therapeutics All rights reserved.
    Website Design: Hane Chow, Inc.